We are proud to announce that our firm is advising Biological E. Ltd, an Indian giant in the biological vaccines sector, on the PDP that will enable the inclusion of a new vaccine aimed at combating pneumonia and meningitis. This represents an important step in expanding access to vaccines in the country and strengthening the National Immunization Program.
Our team worked closely with the company on regulatory, contractual, and strategic matters, reaffirming our commitment to innovation, health, and the development of the pharmaceutical sector in Brazil.
According to Marianne Albers, partner of the Life Sciences practice, “partnerships like this should be celebrated because they are fundamental to ensuring continuous innovation as well as the production of medicines and vaccines within Brazilian territory, thereby reducing the vulnerability of the Unified Health System – SUS. Through technological transfers, it is possible to strengthen the sector and achieve Brazil’s full independence in vaccine production.”
Read the full article here (available only in portuguese).
